Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
JAK inhibitors ∼ overview∼.
Kameda H. Kameda H. Immunol Med. 2023 Sep;46(3):108-111. doi: 10.1080/25785826.2023.2183594. Epub 2023 Feb 27. Immunol Med. 2023. PMID: 36850046 Free article. Review.
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
Saeki H, Akiyama M, Abe M, Igarashi A, Imafuku S, Ohya Y, Katoh N, Kameda H, Kabashima K, Tsunemi Y, Hide M, Ohtsuki M; Committee for reviewing the Safety of Atopic Dermatitis/Urticaria Treatment, Japanese Dermatological Association. Saeki H, et al. Among authors: kameda h. J Dermatol. 2023 Jan;50(1):e1-e19. doi: 10.1111/1346-8138.16635. Epub 2022 Nov 22. J Dermatol. 2023. PMID: 36412059
English version of Japanese guidance for biologics in treating atopic dermatitis.
Saeki H, Akiyama M, Abe M, Igarashi A, Imafuku S, Ohya Y, Katoh N, Kameda H, Kabashima K, Tsunemi Y, Hide M, Ohtsuki M; Committee for reviewing the safety of atopic dermatitis/urticaria treatment, Japanese Dermatological Association. Saeki H, et al. Among authors: kameda h. J Dermatol. 2023 Oct;50(10):e311-e322. doi: 10.1111/1346-8138.16932. Epub 2023 Aug 31. J Dermatol. 2023. PMID: 37650357
Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades.
Imaizumi C, Ogura T, Inoue Y, Takakura Y, Katagiri T, Takenaka S, Ito H, Mizushina K, Hirata A, Kameda H. Imaizumi C, et al. Among authors: kameda h. Intern Med. 2022;61(21):3189-3196. doi: 10.2169/internalmedicine.7609-21. Epub 2022 Nov 1. Intern Med. 2022. PMID: 36328585 Free PMC article.
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
Braun J, Blanco R, Marzo-Ortega H, Gensler LS, Van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, van der Heijde D, Zhuang T, Stefanska A, Readie A, Richards HB, Deodhar A. Braun J, et al. Among authors: kameda h. Arthritis Res Ther. 2023 May 16;25(1):80. doi: 10.1186/s13075-023-03051-5. Arthritis Res Ther. 2023. PMID: 37194094 Free PMC article. Clinical Trial.
547 results